ANTI-HYPERGLYCEMIC DIABETES AGENTS in T2DM – Outcomes Comparison Summary Table (2021) L Regier BSP BA

Description

A comprehensive summary table comparing the major clinical outcomes (MACE, mortality) and supporting randomized controlled trials for different classes of anti-hyperglycemic agents used in the treatment of Type 2 Diabetes Mellitus (T2DM), including Metformin, Sulfonylureas, TZDs, DPP4 Inhibitors, GLP1 Agonists, and SGLT2 Inhibitors.